Jump to content
Telehealth CJC-1295

A plain-language, accessibility-first digest of the CJC-1295 research literature and its regulatory standing - what the studies measured, and where this peptide actually sits with the FDA and WADA.

Study facts without medical care or sales

About Telehealth CJC-1295

This CJC-1295 guide explains what researchers found, what remains unknown, and which public rules may affect you.

This guide tells you what studies did and didn't prove

A longer hormone order was ConjuChem's aim when the drug company created CJC-1295. Early studies saw the longer effect in blood but left large safety questions.

Here you can see who took CJC-1295, what changed in their bodies, and how long researchers watched. Those facts help you separate a blood result from a claim that someone felt better.

For your choice, results from human volunteers matter more than results in mice or rats. Animal results are still named as animal results, since they can't promise what happens to you.

This guide can't diagnose you or write a prescription. It isn't a clinic, pharmacy, seller, or place to obtain CJC-1295.

Bracketed numbers lead to the original reports. You can check a finding without relying on a sales page.

Telehealth in the name does not mean a clinic

Interest in ConjuChem's drug spread far beyond its first studies. The word telehealth in this name doesn't mean anyone offers care here.

You can't book a doctor, get a prescription, or reach a pharmacy through these pages. The site only explains public research.

CJC-1295 isn't approved for people. An FDA group also opposed using it as a main ingredient for pharmacy mixing in 2024 [13].

The world sports drug authority bans the drug for tested athletes [15]. You can read those rules here, but you can't receive care.

Results in people and animals answer different questions

ConjuChem wanted a longer hormone effect, and early work found one in blood. That finding doesn't become a promise of better health.

The full reference list includes studies in people, mice, and rats. Each result names who or what was tested, so an animal result isn't mistaken for proof about you.

Important proof is still missing. No large study followed human safety for years, and the long DAC program stopped.

Public records do not settle the patient's death linked in reports to that work, so they cannot tell you that the drug caused it or rule the drug out. The cause is unknown, so guessing would mislead you.

The DAC form leaves slowly, while the unhooked form can leave much faster. Mixing their names can leave you with the wrong time.

What matters is who was studied, what changed, and what no one has answered. The unanswered parts matter as much as the hormone results.